death from semaglutide lowers risk of kidney failure and cardiovascular in patients with type 2 diabetes and CKD, study results show Off-Label Semaglutide Linked to Deaths,

That creates a marketing opportunity: products can borrow the GLP-1 label and imply similar results, even when the product is not a prescription medication and does not contain a GLP-1 drug

During the second half of the month, I began paying closer attention to my daily calorie intake, and I pushed myself to exercise more

GLP-1 drugs like semaglutide help lower blood sugar and cut down heart risks in patients more likely to have heart problems

Pharmaceuticals (MDPI) 2026, 18 (2): 185

Appetite changes : Given its mechanism of action, Semaglutide can significantly reduce appetite, which, while beneficial for weight loss, may lead to inadequate nutritional intake if not carefully monitored

Although evidence suggests that astragaloside IV holds promise in arrhythmia treatment, comprehensive reviews of its specific mechanisms and clinical applications in arrhythmia are scarce